Anže combines global experience across IVD oncology diagnostics, NGS, laboratory automation, and GMP pharmaceutical manufacturing, developed within regulated environments in both Europe and the United States. Throughout his career, he has led complex, multi-million biotechnology programs spanning R&D, clinical execution, regulatory compliance, infrastructure build-out, and cross-functional leadership.

His background bridges molecular technologies, automated laboratory systems, and compliant production operations — providing a full-spectrum understanding of how biotech companies move from concept to regulated deployment.

Today, in the cell and gene therapy space, he applies this integrated perspective to operational strategy, platform scalability, and international business development — aligning scientific innovation with disciplined execution and sustainable growth.